GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Glycomimetics Inc (GLYC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 9,544,262 | $2,687,664 | 0.07% | |
| 2. | Renaissance Technologies Jim Simons | 826,851 | $232,841 | +484% | 0% |
| 3. | 650,000 | $183,040 | +98% | 0% | |
| 4. | Millennium Management Israel Englander | 186,227 | $52,442 | -76% | 0% |
| 5. | 135,000 | $38,016 | -3% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.27 | 115,000 | 680,403 | 2024-06-21 | Filing | ||
| $0.25 | 190,000 | 565,403 | 2024-06-20 | Filing | ||
| $0.25 | 17,500 | 70,643 | 2024-06-18 | Filing | ||
| $1.38 | 30,403 | Officer | 375,403 | 2023-09-22 | Filing | |
| $1.38 | 35,000 | Officer | 345,000 | 2023-09-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.19 | 260,873 | 6,317,565 | 2024-08-08 | Filing | ||
| $0.18 | 61,488 | 6,578,438 | 2024-08-07 | Filing | ||
| $0.18 | 55,732 | 6,639,926 | 2024-08-06 | Filing | ||
| $0.19 | 164,523 | 6,695,658 | 2024-08-05 | Filing | ||
| $0.20 | 286,200 | 6,860,181 | 2024-08-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,764,440 | $11,244,079 | 0.74% | |
| 2. | 2,421,869 | $5,715,611 | 0% | |
| 3. | 1,587,298 | $3,746,023 | 0.01% | |
| 4. | 919,355 | $2,169,678 | 0% | |
| 5. | 734,983 | $1,734,560 | 0% |
News See All
GlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining the GlycoMimetics Q3 2023 Earnings Call. At this time, all participants are in a listen-only mode.
GlycoMimetics, Inc. (NASDAQ:GLYC) Q2 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining the GlycoMimetics, Q2 2023 Earnings Call. At this time all participants are in listen-only mode.
12 Best Multibagger Penny Stocks To Buy
Apple Inc. (NASDAQ:AAPL). Amazon.com, Inc. (NASDAQ:AMZN). Microsoft Corporation (NASDAQ:MSFT). Alphabet Inc. (NASDAQ:GOOG). Meta Platforms, Inc. (NASDAQ:META).
GlycoMimetics, Inc. (NASDAQ:GLYC) Q1 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining the GlycoMimetics Q1 2023 Earnings Call. At this time, all participants are in listen-only mode.
GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2022 Earnings Call Transcript
Operator: Good morning. And thank you for joining the GlycoMimetics Fourth Quarter and Full Year 2022 Earnings Call. At this time, all participants are in a listen only mode.
Hedge Funds Are Dumping GlycoMimetics, Inc. (GLYC)
At Insider Monkey, we pore over the filings of nearly 873 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is GLYC A Good Stock To Buy Now?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious...
Were Hedge Funds Right About Piling Into GlycoMimetics, Inc. (GLYC)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Dropped The Ball On GlycoMimetics, Inc. (GLYC)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...